Propofol Patent Expiration

Propofol is Used for preventing microbial growth, administering over a longer period, and inducing anesthesia. It was first introduced by Fresenius Kabi Usa Llc in its drug Diprivan on Oct 2, 1989. 11 different companies have introduced drugs containing Propofol.


Propofol Patents

Given below is the list of patents protecting Propofol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Diprivan US8476010

(Pediatric)

Propofol formulations with non-reactive container closures Jun 01, 2025 Fresenius Kabi Usa
Diprivan US8476010 Propofol formulations with non-reactive container closures Dec 01, 2024 Fresenius Kabi Usa
Diprivan US5714520

(Pediatric)

Propofol compostion containing edetate Sep 22, 2015

(Expired)

Fresenius Kabi Usa
Diprivan US5731355

(Pediatric)

Pharmaceutical compositions of propofol and edetate Sep 22, 2015

(Expired)

Fresenius Kabi Usa
Diprivan US5731356

(Pediatric)

Pharmaceutical compositions of propofol and edetate Sep 22, 2015

(Expired)

Fresenius Kabi Usa
Diprivan US5908869

(Pediatric)

Propofol compositions containing edetate Sep 22, 2015

(Expired)

Fresenius Kabi Usa
Diprivan US5714520 Propofol compostion containing edetate Mar 22, 2015

(Expired)

Fresenius Kabi Usa
Diprivan US5731355 Pharmaceutical compositions of propofol and edetate Mar 22, 2015

(Expired)

Fresenius Kabi Usa
Diprivan US5731356 Pharmaceutical compositions of propofol and edetate Mar 22, 2015

(Expired)

Fresenius Kabi Usa
Diprivan US5908869 Propofol compositions containing edetate Mar 22, 2015

(Expired)

Fresenius Kabi Usa



Propofol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Propofol Generics

Several generic applications have been filed for Propofol. The first generic version for Propofol was by Sagent Pharmaceuticals Inc and was approved on Jan 4, 1999. And the latest generic version is by Amneal Eu Ltd and was approved on Aug 15, 2024.

Given below is the list of companies who have filed for Propofol generic.


1. AMNEAL

Amneal Eu Ltd has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Aug 15, 2024


2. ASPIRO

Aspiro Pharma Ltd has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Jun 20, 2024


3. AVET LIFESCIENCES

Avet Lifesciences Ltd has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Oct 12, 2021


4. DR REDDYS

Dr Reddys Laboratories Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Nov 15, 2018


5. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Apr 19, 2005


6. HOSPIRA

Hospira Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Mar 17, 2006


7. INNOPHARMA

Innopharma Licensing Llc A Sub Of Pfizer Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Innopharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Sep 16, 2020


8. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Prescription INJECTION AB Jan 4, 1999


9. TEVA PARENTERAL

Teva Parenteral Medicines Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Teva Parenteral.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Discontinued INJECTION N/A Sep 19, 2000


10. WATSON LABS INC

Watson Laboratories Inc has filed for 1 generic for Propofol. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML injectable Discontinued INJECTION N/A Dec 22, 2015